Cargando…

Different significance of HRCT and FDG-PET/CT to predict lymph node status between patients with clinical stage IA lung adenocarcinoma and squamous cell carcinoma

Detalles Bibliográficos
Autores principales: Tsutani, Yasuhiro, Miyata, Yoshihiro, Mimura, Takeshi, Ito, Masaoki, Kai, Yuichiro, Kagimoto, Atsushi, Nakayama, Haruhiko, Okumura, Sakae, Yoshimura, Masahiro, Okada, Morihito
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4695719/
http://dx.doi.org/10.1186/1749-8090-10-S1-A332
_version_ 1782407676715597824
author Tsutani, Yasuhiro
Miyata, Yoshihiro
Mimura, Takeshi
Ito, Masaoki
Kai, Yuichiro
Kagimoto, Atsushi
Nakayama, Haruhiko
Okumura, Sakae
Yoshimura, Masahiro
Okada, Morihito
author_facet Tsutani, Yasuhiro
Miyata, Yoshihiro
Mimura, Takeshi
Ito, Masaoki
Kai, Yuichiro
Kagimoto, Atsushi
Nakayama, Haruhiko
Okumura, Sakae
Yoshimura, Masahiro
Okada, Morihito
author_sort Tsutani, Yasuhiro
collection PubMed
description
format Online
Article
Text
id pubmed-4695719
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-46957192016-01-07 Different significance of HRCT and FDG-PET/CT to predict lymph node status between patients with clinical stage IA lung adenocarcinoma and squamous cell carcinoma Tsutani, Yasuhiro Miyata, Yoshihiro Mimura, Takeshi Ito, Masaoki Kai, Yuichiro Kagimoto, Atsushi Nakayama, Haruhiko Okumura, Sakae Yoshimura, Masahiro Okada, Morihito J Cardiothorac Surg Meeting Abstract BioMed Central 2015-12-16 /pmc/articles/PMC4695719/ http://dx.doi.org/10.1186/1749-8090-10-S1-A332 Text en Copyright © 2015 Tsutani et al. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Meeting Abstract
Tsutani, Yasuhiro
Miyata, Yoshihiro
Mimura, Takeshi
Ito, Masaoki
Kai, Yuichiro
Kagimoto, Atsushi
Nakayama, Haruhiko
Okumura, Sakae
Yoshimura, Masahiro
Okada, Morihito
Different significance of HRCT and FDG-PET/CT to predict lymph node status between patients with clinical stage IA lung adenocarcinoma and squamous cell carcinoma
title Different significance of HRCT and FDG-PET/CT to predict lymph node status between patients with clinical stage IA lung adenocarcinoma and squamous cell carcinoma
title_full Different significance of HRCT and FDG-PET/CT to predict lymph node status between patients with clinical stage IA lung adenocarcinoma and squamous cell carcinoma
title_fullStr Different significance of HRCT and FDG-PET/CT to predict lymph node status between patients with clinical stage IA lung adenocarcinoma and squamous cell carcinoma
title_full_unstemmed Different significance of HRCT and FDG-PET/CT to predict lymph node status between patients with clinical stage IA lung adenocarcinoma and squamous cell carcinoma
title_short Different significance of HRCT and FDG-PET/CT to predict lymph node status between patients with clinical stage IA lung adenocarcinoma and squamous cell carcinoma
title_sort different significance of hrct and fdg-pet/ct to predict lymph node status between patients with clinical stage ia lung adenocarcinoma and squamous cell carcinoma
topic Meeting Abstract
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4695719/
http://dx.doi.org/10.1186/1749-8090-10-S1-A332
work_keys_str_mv AT tsutaniyasuhiro differentsignificanceofhrctandfdgpetcttopredictlymphnodestatusbetweenpatientswithclinicalstageialungadenocarcinomaandsquamouscellcarcinoma
AT miyatayoshihiro differentsignificanceofhrctandfdgpetcttopredictlymphnodestatusbetweenpatientswithclinicalstageialungadenocarcinomaandsquamouscellcarcinoma
AT mimuratakeshi differentsignificanceofhrctandfdgpetcttopredictlymphnodestatusbetweenpatientswithclinicalstageialungadenocarcinomaandsquamouscellcarcinoma
AT itomasaoki differentsignificanceofhrctandfdgpetcttopredictlymphnodestatusbetweenpatientswithclinicalstageialungadenocarcinomaandsquamouscellcarcinoma
AT kaiyuichiro differentsignificanceofhrctandfdgpetcttopredictlymphnodestatusbetweenpatientswithclinicalstageialungadenocarcinomaandsquamouscellcarcinoma
AT kagimotoatsushi differentsignificanceofhrctandfdgpetcttopredictlymphnodestatusbetweenpatientswithclinicalstageialungadenocarcinomaandsquamouscellcarcinoma
AT nakayamaharuhiko differentsignificanceofhrctandfdgpetcttopredictlymphnodestatusbetweenpatientswithclinicalstageialungadenocarcinomaandsquamouscellcarcinoma
AT okumurasakae differentsignificanceofhrctandfdgpetcttopredictlymphnodestatusbetweenpatientswithclinicalstageialungadenocarcinomaandsquamouscellcarcinoma
AT yoshimuramasahiro differentsignificanceofhrctandfdgpetcttopredictlymphnodestatusbetweenpatientswithclinicalstageialungadenocarcinomaandsquamouscellcarcinoma
AT okadamorihito differentsignificanceofhrctandfdgpetcttopredictlymphnodestatusbetweenpatientswithclinicalstageialungadenocarcinomaandsquamouscellcarcinoma